Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer
Oncogene, 05/15/2012
Ahlqvist K et al. – The data imply that inactivation of B–cell leukemia 3 (Bcl–3) may lead to sensitization of cancer cells to chemotherapeutic drug–induced apoptosis, thus suggesting a potential therapeutic strategy in prostate cancer (PCa) treatment.



